chizzik1

10 Biotechs in Stem Cells that Could Profit Under the Democrats

Richard Garr CEO of Neuralstem(CUR) wrote in his CEO Blog of May 19th,

"The first thing to remember, is that our cells are “committed” neural precursors. That is, they are already programmed by nature to “turn into” the cells of the central nervous system, and ONLY the central nervous system. This is a crucial distinction. The “turning into” process, we call differentiation. And the way we characterize this process is to say that we have completely “controlled” differentiation. The cells only, and always, become what we want them to become. We have a completely controlled differentiation, and we have never seen any tumors in any of the studies we have conducted with the cells; both in chemically immune suppressed animals or in genetically bred immune suppressed animals, nor in healthy animals".

As you can see, this blog has Neuralstem catagorized incorrectly.

BTW, Neuralstem expects to file an IND to treat ALS this fall.